NCT03928964Unknown不适用
Pronostic Assessment of Mortality Among Locally Advanced or Metastatic Renal Cell Carcinoma Patients After First Line Treatment : Multicenter Prospective Cohort Study With Historic Medical Data
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 440
- 试验地点
- 8
- 主要终点
- Overall survival after the first line of treatment
研究概览
简要总结
The hypothesis of this study are as follows:
- Prognostic evaluation of patients based on an integrative model provides better assessment of overall survival, and thus improves setting of care goals.
- In a routine care population, antitumour drugs may have a significant impact on overall survival through their targeted antitumor effect, but also through their toxicity profile and their impact on comorbidities.
- The optimization of patient support (supportive care, drug tolerance monitoring) can have an impact on the prognosis.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Overall survival after the first line of treatment
时间窗: year 11
Time elapsed between initiation date for 2nd line treatment et the date of death, whatever the cause.
次要结局
未报告次要终点
研究者
研究点 (8)
Loading locations...
相似试验
Unknown
不适用
Derivation and Validation of a Prognostic Model for Septic Patients at Hospital AdmissionSepsisNCT03601767Azienda Ospedaliera San Paolo600
已完成
不适用
Mortality Analysis of ST Elevation Myocardial Infarction (STEMI) Patients in BelgiumAcute Myocardial InfarctionNCT00727623Universiteit Antwerpen20,000
已完成
不适用
Prospective Validation of Clini-biological Parameters Including Initial Hemostasis, Which Improve the Prediction of Death at 1 Month Among Patients With Septic ShockShock, SepticNCT01231672Centre Hospitalier Universitaire de Nīmes780
已完成
不适用
Relationship Between Potential Predictors and Mortality in COVID-19 Patients ın TurkeyCovid19NCT04789460Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey816
招募中
不适用
Identification of prognostic factors in locally advanced and recurrent patients (multicenter collaborative research)ocal advanced and recurrent metastatic breast cancerJPRN-UMIN000035772Hyogo college of Medicine100
